Cargando…
Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma
BACKGROUND: This study aimed to validate whether infusion of GD2-specific fourth-generation safety-designed chimeric antigen receptor (4SCAR)-T cells is safe and whether CAR-T cells exert anti-glioblastoma (GBM) activity. METHODS: A total of eight patients with GD2-positive GBM were enrolled and inf...
Autores principales: | Liu, Zhuohao, Zhou, Jiayi, Yang, Xinzhi, Liu, Yuchen, Zou, Chang, Lv, Wen, Chen, Cheng, Cheng, Kenneth King-yip, Chen, Tao, Chang, Lung-Ji, Wu, Dinglan, Mao, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827625/ https://www.ncbi.nlm.nih.gov/pubmed/36617554 http://dx.doi.org/10.1186/s12943-022-01711-9 |
Ejemplares similares
-
Nuclear factor IX promotes glioblastoma development through transcriptional activation of Ezrin
por: Liu, Zhuohao, et al.
Publicado: (2020) -
miR-18a promotes glioblastoma development by down-regulating ALOXE3-mediated ferroptotic and anti-migration activities
por: Yang, Xinzhi, et al.
Publicado: (2021) -
Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma
por: Zhou, Jiayi, et al.
Publicado: (2021) -
4SCAR‐GD2‐modified T‐cell therapy in neuroblastoma with MYCN amplification: A case report with over 4‐year follow‐up data
por: Xu, Xiao, et al.
Publicado: (2020) -
GD2 CAR T cells against human glioblastoma
por: Prapa, Malvina, et al.
Publicado: (2021)